Annual Drug Patent Expirations for NYMALIZE
Nymalize is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.
This drug has two patent family members in two countries.
The generic ingredient in NYMALIZE is nimodipine. One supplier is listed for this compound. Additional details are available on the nimodipine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published at New patent for Azurity drug NYMALIZE